A citation-based method for searching scientific literature

Richard Flavin, Andreas Pettersson, Whitney K Hendrickson, Michelangelo Fiorentino, Stephen Finn, Lauren Kunz, Gregory L Judson, Rosina Lis, Dyane Bailey, Christopher Fiore, Elizabeth Nuttall, Neil E Martin, Edward Stack, Kathryn L Penney, Jennifer R Rider, Jennifer Sinnott, Christopher Sweeney, Howard D Sesso, Katja Fall, Edward Giovannucci, Philip Kantoff, Meir Stampfer, Massimo Loda, Lorelei A Mucci. Clin Cancer Res 2014
Times Cited: 47







List of co-cited articles
381 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The role of SPINK1 in ETS rearrangement-negative prostate cancers.
Scott A Tomlins, Daniel R Rhodes, Jianjun Yu, Sooryanarayana Varambally, Rohit Mehra, Sven Perner, Francesca Demichelis, Beth E Helgeson, Bharathi Laxman, David S Morris,[...]. Cancer Cell 2008
226
68

Association of SPINK1 expression and TMPRSS2:ERG fusion with prognosis in endocrine-treated prostate cancer.
Katri A Leinonen, Teemu T Tolonen, Hazel Bracken, Ulf-Håkan Stenman, Teuvo L J Tammela, Outi R Saramäki, Tapio Visakorpi. Clin Cancer Res 2010
82
40

Therapeutic targeting of SPINK1-positive prostate cancer.
Bushra Ateeq, Scott A Tomlins, Bharathi Laxman, Irfan A Asangani, Qi Cao, Xuhong Cao, Yong Li, Xiaoju Wang, Felix Y Feng, Kenneth J Pienta,[...]. Sci Transl Med 2011
109
34

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Scott A Tomlins, Daniel R Rhodes, Sven Perner, Saravana M Dhanasekaran, Rohit Mehra, Xiao-Wei Sun, Sooryanarayana Varambally, Xuhong Cao, Joelle Tchinda, Rainer Kuefer,[...]. Science 2005
27

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence.
Katharina Grupp, Franz Diebel, Hüseyin Sirma, Ronald Simon, Karin Breitmeyer, Stefan Steurer, Claudia Hube-Magg, Kristina Prien, Taher Pham, Philipp Weigand,[...]. Prostate 2013
29
41


Increased expression of tumor-associated trypsin inhibitor, TATI, in prostate cancer and in androgen-independent 22Rv1 cells.
Annukka Paju, Kristina Hotakainen, Yue Cao, Timo Laurila, Virgil Gadaleanu, Akseli Hemminki, Ulf-Håkan Stenman, Anders Bjartell. Eur Urol 2007
63
21

Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer.
Katri A Leinonen, Outi R Saramäki, Bungo Furusato, Takahiro Kimura, Hiroyuki Takahashi, Shin Egawa, Hiroyoshi Suzuki, Kerri Keiger, Sung Ho Hahm, William B Isaacs,[...]. Cancer Epidemiol Biomarkers Prev 2013
93
21

Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.
Stéphane Terry, Nathalie Nicolaiew, Victor Basset, Fannie Semprez, Pascale Soyeux, Pascale Maillé, Francis Vacherot, Guillaume Ploussard, Arturo Londoño-Vallejo, Alexandre de la Taille,[...]. Cancer 2015
24
41

Novel dual-color immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma.
Ritu Bhalla, Lakshmi P Kunju, Scott A Tomlins, Kelly Christopherson, Connie Cortez, Shannon Carskadon, Javed Siddiqui, Kyung Park, Juan Miguel Mosquera, Gary A Pestano,[...]. Mod Pathol 2013
33
27

Integrative genomic profiling of human prostate cancer.
Barry S Taylor, Nikolaus Schultz, Haley Hieronymus, Anuradha Gopalan, Yonghong Xiao, Brett S Carver, Vivek K Arora, Poorvi Kaushik, Ethan Cerami, Boris Reva,[...]. Cancer Cell 2010
19

The mutational landscape of lethal castration-resistant prostate cancer.
Catherine S Grasso, Yi-Mi Wu, Dan R Robinson, Xuhong Cao, Saravana M Dhanasekaran, Amjad P Khan, Michael J Quist, Xiaojun Jing, Robert J Lonigro, J Chad Brenner,[...]. Nature 2012
19

Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
Scott A Tomlins, Mohammed Alshalalfa, Elai Davicioni, Nicholas Erho, Kasra Yousefi, Shuang Zhao, Zaid Haddad, Robert B Den, Adam P Dicker, Bruce J Trock,[...]. Eur Urol 2015
94
19

Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer.
Chunni Wang, Lin Wang, Bo Su, Ning Lu, Jingjing Song, Xiaoqing Yang, Weiwei Fu, Weiwei Tan, Bo Han. Prostate 2014
38
21

Antibody-based detection of ERG rearrangement-positive prostate cancer.
Kyung Park, Scott A Tomlins, Kumaran M Mudaliar, Ya-Lin Chiu, Raquel Esgueva, Rohit Mehra, Khalid Suleman, Sooryanarayana Varambally, John C Brenner, Theresa MacDonald,[...]. Neoplasia 2010
256
17

Prostate cancer SubtyPINg biomarKers and outcome: is clarity emERGing?
Steven C Smith, Scott A Tomlins. Clin Cancer Res 2014
13
61

TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
F Demichelis, K Fall, S Perner, O Andrén, F Schmidt, S R Setlur, Y Hoshida, J-M Mosquera, Y Pawitan, C Lee,[...]. Oncogene 2007
464
17


Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor.
Nobuyuki Ozaki, Masaki Ohmuraya, Masahiko Hirota, Satoshi Ida, Jun Wang, Hiroshi Takamori, Shigeki Higashiyama, Hideo Baba, Ken-Ichi Yamamura. Mol Cancer Res 2009
69
14

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer.
R K Nam, L Sugar, W Yang, S Srivastava, L H Klotz, L-Y Yang, A Stanimirovic, E Encioiu, M Neill, D A Loblaw,[...]. Br J Cancer 2007
187
14

A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Eric A Klein, Matthew R Cooperberg, Cristina Magi-Galluzzi, Jeffry P Simko, Sara M Falzarano, Tara Maddala, June M Chan, Jianbo Li, Janet E Cowan, Athanasios C Tsiatis,[...]. Eur Urol 2014
377
14

Recurrent gene fusions in prostate cancer.
Chandan Kumar-Sinha, Scott A Tomlins, Arul M Chinnaiyan. Nat Rev Cancer 2008
499
14

Evidence for molecular differences in prostate cancer between African American and Caucasian men.
Francesca Khani, Juan Miguel Mosquera, Kyung Park, Mirjam Blattner, Catherine O'Reilly, Theresa Y MacDonald, Zhengming Chen, Abhishek Srivastava, Ashutosh K Tewari, Christopher E Barbieri,[...]. Clin Cancer Res 2014
101
14

SPINK1 Defines a Molecular Subtype of Prostate Cancer in Men with More Rapid Progression in an at Risk, Natural History Radical Prostatectomy Cohort.
Michael H Johnson, Ashley E Ross, Mohammed Alshalalfa, Nicholas Erho, Kasra Yousefi, Stephanie Glavaris, Helen Fedor, Misop Han, Sheila F Faraj, Stephania M Bezerra,[...]. J Urol 2016
27
25

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer.
Christopher E Barbieri, Sylvan C Baca, Michael S Lawrence, Francesca Demichelis, Mirjam Blattner, Jean-Philippe Theurillat, Thomas A White, Petar Stojanov, Eliezer Van Allen, Nicolas Stransky,[...]. Nat Genet 2012
948
12

ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification.
B Furusato, S-H Tan, D Young, A Dobi, C Sun, A A Mohamed, R Thangapazham, Y Chen, G McMaster, T Sreenath,[...]. Prostate Cancer Prostatic Dis 2010
179
12

Increased survival with enzalutamide in prostate cancer after chemotherapy.
Howard I Scher, Karim Fizazi, Fred Saad, Mary-Ellen Taplin, Cora N Sternberg, Kurt Miller, Ronald de Wit, Peter Mulders, Kim N Chi, Neal D Shore,[...]. N Engl J Med 2012
12

TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.
Outi R Saramäki, Anna E Harjula, Paula M Martikainen, Robert L Vessella, Teuvo L J Tammela, Tapio Visakorpi. Clin Cancer Res 2008
185
12

The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.
Andreas Pettersson, Rebecca E Graff, Scott R Bauer, Michael J Pitt, Rosina T Lis, Edward C Stack, Neil E Martin, Lauren Kunz, Kathryn L Penney, Azra H Ligon,[...]. Cancer Epidemiol Biomarkers Prev 2012
208
12

Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.
R Jeffrey Karnes, Eric J Bergstralh, Elai Davicioni, Mercedeh Ghadessi, Christine Buerki, Anirban P Mitra, Anamaria Crisan, Nicholas Erho, Ismael A Vergara, Lucia L Lam,[...]. J Urol 2013
227
12

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy.
Nicholas Erho, Anamaria Crisan, Ismael A Vergara, Anirban P Mitra, Mercedeh Ghadessi, Christine Buerki, Eric J Bergstralh, Thomas Kollmeyer, Stephanie Fink, Zaid Haddad,[...]. PLoS One 2013
366
12

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
12

The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer.
Xiuyi Pan, Xingming Zhang, Jing Gong, Junya Tan, Xiaoxue Yin, Qidun Tang, Kunpeng Shu, Pengfei Shen, Hao Zeng, Ni Chen. Prostate 2016
16
37

Emerging Roles of SPINK1 in Cancer.
Kati Räsänen, Outi Itkonen, Hannu Koistinen, Ulf-Håkan Stenman. Clin Chem 2016
35
17

Punctuated evolution of prostate cancer genomes.
Sylvan C Baca, Davide Prandi, Michael S Lawrence, Juan Miguel Mosquera, Alessandro Romanel, Yotam Drier, Kyung Park, Naoki Kitabayashi, Theresa Y MacDonald, Mahmoud Ghandi,[...]. Cell 2013
730
10

PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients.
Tamara L Lotan, Bora Gurel, Siobhan Sutcliffe, David Esopi, Wennuan Liu, Jianfeng Xu, Jessica L Hicks, Ben H Park, Elizabeth Humphreys, Alan W Partin,[...]. Clin Cancer Res 2011
233
10

Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.
Vivek K Arora, Emily Schenkein, Rajmohan Murali, Sumit K Subudhi, John Wongvipat, Minna D Balbas, Neel Shah, Ling Cai, Eleni Efstathiou, Chris Logothetis,[...]. Cell 2013
538
10

Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer.
G Attard, J Clark, L Ambroisine, G Fisher, G Kovacs, P Flohr, D Berney, C S Foster, A Fletcher, W L Gerald,[...]. Oncogene 2008
343
10

SPINK1 Status in Colorectal Cancer, Impact on Proliferation, and Role in Colitis-Associated Cancer.
Satoshi Ida, Nobuyuki Ozaki, Kimi Araki, Kotaro Hirashima, Yoko Zaitsu, Katsunobu Taki, Yasuo Sakamoto, Yuji Miyamoto, Eiji Oki, Masaru Morita,[...]. Mol Cancer Res 2015
18
27

SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression.
R Tiwari, S K Pandey, S Goel, V Bhatia, S Shukla, X Jing, S M Dhanasekaran, B Ateeq. Oncogenesis 2015
30
16

Serine Protease Inhibitor Kazal Type 1 (SPINK1) Promotes Proliferation of Colorectal Cancer Through the Epidermal Growth Factor as a Prognostic Marker.
Yi-Ting Chen, Shu-Chuan Tsao, Shyng-Shiou F Yuan, Hung-Pei Tsai, Chee-Yin Chai. Pathol Oncol Res 2015
13
38

Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients.
James D Brooks, Wei Wei, Sarah Hawley, Heidi Auman, Lisa Newcomb, Hilary Boyer, Ladan Fazli, Jeff Simko, Antonio Hurtado-Coll, Dean A Troyer,[...]. PLoS One 2015
22
22

SPOP mutations in prostate cancer across demographically diverse patient cohorts.
Mirjam Blattner, Daniel J Lee, Catherine O'Reilly, Kyung Park, Theresa Y MacDonald, Francesca Khani, Kevin R Turner, Ya-Lin Chiu, Peter J Wild, Igor Dolgalev,[...]. Neoplasia 2014
92
10

A Prospective Investigation of PTEN Loss and ERG Expression in Lethal Prostate Cancer.
Thomas U Ahearn, Andreas Pettersson, Ericka M Ebot, Travis Gerke, Rebecca E Graff, Carlos L Morais, Jessica L Hicks, Kathryn M Wilson, Jennifer R Rider, Howard D Sesso,[...]. J Natl Cancer Inst 2015
104
10

Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer.
Sameer Jhavar, Daniel Brewer, Sandra Edwards, Zsofia Kote-Jarai, Gerhardt Attard, Jeremy Clark, Penny Flohr, Timothy Christmas, Alan Thompson, Matthew Parker,[...]. BJU Int 2009
50
8

HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.
Steven C Smith, Nallasivam Palanisamy, Kimberly A Zuhlke, Anna M Johnson, Javed Siddiqui, Arul M Chinnaiyan, Lakshmi P Kunju, Kathleen A Cooney, Scott A Tomlins. Am J Surg Pathol 2014
28
14

Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer.
Tarek A Bismar, Maisa Yoshimoto, Qiuli Duan, Shuhong Liu, Kanishka Sircar, Jeremy A Squire. Histopathology 2012
38
10

SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
Zhihu Ding, Chang-Jiun Wu, Gerald C Chu, Yonghong Xiao, Dennis Ho, Jingfang Zhang, Samuel R Perry, Emma S Labrot, Xiaoqiu Wu, Rosina Lis,[...]. Nature 2011
344
8

ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.
Changmeng Cai, Hongyun Wang, Housheng Hansen He, Sen Chen, Lingfeng He, Fen Ma, Lorelei Mucci, Qianben Wang, Christopher Fiore, Adam G Sowalsky,[...]. J Clin Invest 2013
158
8

The genomic complexity of primary human prostate cancer.
Michael F Berger, Michael S Lawrence, Francesca Demichelis, Yotam Drier, Kristian Cibulskis, Andrey Y Sivachenko, Andrea Sboner, Raquel Esgueva, Dorothee Pflueger, Carrie Sougnez,[...]. Nature 2011
869
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.